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To elucidate the functional significance of genome multiplication in somatic tissues, we performed a large-scale analysis of ploidy-associated
changes in expression of non-tissue-specific (i.e., broadly expressed) genes in the heart and liver of human and mouse (6585 homologous genes
were analyzed). These species have inverse patterns of polyploidization in cardiomyocytes and hepatocytes. The between-species comparison of
two pairs of homologous tissues with crisscross contrast in ploidy levels allows the removal of the effects of species and tissue specificity on the
profile of gene activity. The different tests performed from the standpoint of modular biology revealed a consistent picture of ploidy-associated
alteration in a wide range of functional gene groups. The major effects consisted of hypoxia-inducible factor-triggered changes in main cellular
processes and signaling pathways, activation of defense against DNA lesions, acceleration of protein turnover and transcription, and the
impairment of apoptosis, the immune response, and cytoskeleton maintenance. We also found a severe decline in aerobic respiration and
stimulation of sugar and fatty acid metabolism. These metabolic rearrangements create a special type of metabolism that can be considered
intermediate between aerobic and anaerobic. The metabolic and physiological changes revealed (reflected in the alteration of gene expression)
help explain the unique ability of polyploid tissues to combine proliferation and differentiation, which are separated in diploid tissues. We argue
that genome multiplication promotes cell survival and tissue regeneration under stressful conditions.
© 2006 Elsevier Inc. All rights reserved.Keywords: Gene expression; Expression modules; Pathways; Somatic polyploidy; Cardiomyocytes; Hepatocytes; Hypoxia; Stress; Metabolism; DNA repair;
Survival; Human; MouseIntroduction
The accumulation of several diploid genome sets in cells of a
separate tissue (called somatic polyploidy) is a widespread
phenomenon observed in various organs in animals, plants, and
fungi under physiological and pathological conditions [1,2].
Homologous mammalian tissues demonstrate great diversity in
the degree of genome multiplication: some species have
predominantly polyploid heart and diploid liver (pig, human,
and other primates), whereas others possess mainly polyploid
liver and predominantly diploid heart (rodents) [1–3]. The
mechanism of polyploid cell formation is common in various
definitive mammalian tissues, including heart and liver.
Genome doubling takes place during the cell cycle with
reduction of mitosis. If only cell division (cytokinesis) is⁎ Corresponding author.
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doi:10.1016/j.ygeno.2006.08.014omitted, polyploid cells with multiple nuclei arise; if the
preceding stage (karyokinesis) is also dropped, cells with large
polyploid nuclei appear (the latter process is referred to as
endocycle or endoreduplication) [2]. Polyploidization is an
irreversible process that takes place only in those tissues where
cell proliferation and differentiation proceed simultaneously
[1,4]. The adult mammalian heart and liver maintain cell ploidy
levels that were established as far back as early postnatal
ontogenesis despite the ability for cell renewal [1,4].
In the vast majority of diploid cells of unicellular and
multicellular organisms, proliferation is temporally and/or
spatially separated from other functions (e.g., tissue-specific)
because it differs in the source of energy. DNA replication and
cell division obtain energy exclusively from anaerobic path-
ways, whereas protein synthesis (the most energy-demanding
process) is fueled predominantly by aerobic energetics [5,6]. It
was suggested that this separation is an important strategy for
prevention of oxidative damage to genetic material during DNA
Table 1
The ploidy-associated changes in gene expression revealed by multiple tests
Functional groups Variant I Variant II
with subgroups and
direction of changes
(↑ or ↓)
Overrepresentation
(subvariant Ia)
Fold direction
(subvariant Ib)
↑DNA repair p<0.001;
q a<0.04
p<0.02 p<0.001;
q<0.04
↑Response to hypoxia b p, NS;
q, NS
p<0.0002 p<0.0002;
q<0.004
↓Immunity p<0.03;
q, NS
p<0.05 p<0.003;
q<0.03
↑Abiotic stress response p<0.03;
q, NS
p<0.01 p<0.0062;
q<0.047
↓Apoptosis p<0.04;
q, NS
p<0.01 p<0.001;
q<0.03
↓Respiration p<0.004;
q<0.04
p<0.0001 p<0.00001;
q<0.00001
↑Glycolytic pathways p<0.006;
q, NS
p<0.009 p<0.001;
q<0.03
↑Fatty acid metabolism p<0.001;
q<0.04
p<0.01 p<0.002;
q<0.04
↑Protein turnover p<0.0004;
q<0.04
p<0.0001 p<0.0008;
q<0.03
↑Proliferation p<0.0002;
q<0.04
p<0.02 p<0.001;
q<0.04
↑Transport p<0.02;
q, NS
p<0.0006 p<0.001;
q<0.04
↓Cytoskeletal and
contractile proteins
p<0.0001;
q<0.04
p<0.002 p<0.0006;
q<0.02
↑Transcription p<0.04;
q, NS
p<0.0006 p<0.002;
q<0.02
↑Signal transduction p<0.03;
q, NS
p<0.01 p<0.004;
q<0.03
a q value is the false discovery rate (no q value is presented for subvariant Ib
because there were no multiple tests performed for it).
b Gene Ontology is not fully up to date with regard to the Response to hypoxia
group (compared to the literature); therefore, the overrepresentation test was not
significant. (Generally, the overrepresentation test is too conservative; see
Material and Methods.)
Fig. 1. Genes differentially expressed in polyploid vs. diploid organs. (A) The
total set of genes with altered expression (without genes with unknown
function). (B) The up-regulated genes. (C) The down-regulated genes.
(Percentages show relative numbers of genes).
71O.V. Anatskaya, A.E. Vinogradov / Genomics 89 (2007) 70–80replication [6]. Thus, the simultaneous occurrence of prolifer-
ation and differentiation in polyploid cells can take place only
under specific metabolic conditions that enable the cell to obtain
energy from usually incompatible pathways.
In congruence with this notion, recent comparative
interspecies studies showed that in the highly polyploid
mammalian and avian heart and liver, polyploidization is
associated with a reduction of functional potential [3,7]. Thus,
hepatocyte ploidy is inversely related to the ratio of maximal to
basal metabolic rate (metabolic scope), which is indicative of
hepatic functional potential. The cardiomyocyte ploidy nega-
tively correlates with heart contraction ability and relative heart
mass [3], which is known to reflect cardiac functional potential
[8]. In both cardiomyocytes and hepatocytes, polyploidization
is accompanied by a reduction in protein content per genome
and in intracellular energy supply [3,9,10]. Therefore, it is
important to understand a possible functional significance of
genome multiplication and to reveal conditions favoring this
process.Human and mouse have the inverse patterns of polyploidiza-
tion in cardiomyocytes vs. hepatocytes [10,11], which enables
the removal of the effect of species specificity on the profile of
gene expression while comparing homologous tissues con-
trasted in ploidy levels. Here we performed a large-scale
analysis of ploidy-associated changes in the expression of non-
tissue-specific (i.e., broadly expressed) genes in the heart and
liver of human and mouse, using different tests performed from
the standpoint of modular biology e.g., [12–15].
Results
General picture
Of a total of 6585 genes, 377 genes showed a greater than
twofold difference in expression level. They were predominant-
ly activated rather than suppressed (229 vs. 148; for difference,
p<10-3). Of these genes, 88.3% were changed two- to fourfold,
10%were changed four- to eightfold, and 1.7%were changed by
greater than eightfold in both crisscross comparisons. The
average folds of (species-normalized) gene expression levels for
functional (sub)group functions are presented in Supplementary
Tables 1-10. The results of the fold-direction and the
overrepresentation tests suggest that these genes can be divided
into eight functional groups, with subgroups within them (plus a
72 O.V. Anatskaya, A.E. Vinogradov / Genomics 89 (2007) 70–80group of genes with unknown and other functions). Notably, all
these groups were confirmed by the second main variant of
analysis (i.e., the test for simultaneous discovery of a gene group
applied to the total data set of 6585 genes) (Table 1). The
distribution of genes by functional groups is presented in Fig. 1.
(Genes involved in metabolism are divided into genes related to
respiration and to sugar and lipid metabolism subgroups).
Because a gene can have more than one function and participate
in various physiological pathways, some of the identified genes
appear in multiple categories. The most numerous functional
groups are presented by genes involved in cell protection,
proliferation, hypoxia-inducible pathways, cytoskeleton, me-
tabolism, and protein turnover. The vast majority of genes
(approximately 90%) with greatly changed expression (greater
than fourfold) belong to these groups.
Several features of revealed ploidy-associated alteration in
the profile of gene expression indicate that this is not just a
spurious variation. First, as was stated above, the number of
activated genes was (highly significantly) greater than the
number of suppressed genes (p<10−3). Second, each functional
group demonstrates a predominant vector in expression change
(e.g., the increase in expression of genes encoding inducers and
the decrease in expression of genes encoding inhibitors, which
was revealed by the fold-direction test). For instance, there was
the predominant up-regulation of genes involved in hypoxia
response, DNA repair, lipid metabolism, protein turnover,
proliferation, transcription, transport, and signal transductionFig. 2. The ploidy-associated changes in gene expression revealed by variant II analy
expression of genes involved in a pathway. Pathways with similar functions are gro
switch from aerobic respiration to lipid and glycolytic metabolism, activation of pro
gray-scale: white: p<0.00001 (q<0.00001); light gray: p<0.003 (q<0.02); dark graand the predominant down-regulation of genes involved in
apoptosis, aerobic respiration, and cytoskeleton. Third, there
were the orchestrated changes in expression of genes encoding
proteins acting directly in a metabolic process and genes
encoding their regulators (transcription factors and signaling
transcripts). Fourth, several groups of related genes with very
similar functions were altered in a similar way [e.g., myosin
light chain polypeptides 1, 2, and 3; high-mobility group
(HMG) proteins 1, 2, and 14] (Table 1; Supplementary Tables 1-
8). Generally, we used the approach of emerging modular
biology, which emphasizes whole pathways and other intracel-
lular functional modules rather than single molecules [12–15].
Finally, our results are in good agreement with the literature data
obtained on the molecular and cellular levels (see Results and
Discussion). Below we describe each functional group.
Stress response
There were changes in expression of a number of genes that
can be regarded as protective. The majority of these genes are
well-known inhibitors of apoptosis, onco-suppressors, and DNA
repairing genes (Supplementary Table 1). Thus, from 19
apoptosis-related genes, 16 are regulated in an anti-apoptotic
manner (Table 1, Figs. 2and 3). This result is in good agreement
with the increased resistance to apoptosis observed in polyploid
fibroblasts and lymphoma cells [16,17]. Our data also suggest
that polyploidization promotes defense against DNA damagesis (with pathways as gene sets). Bars represent the mean folds of changes in the
uped. Y axis, pathways; X axis, mean (log-transformed) fold changes. Note the
tein synthesis, signaling, and proliferation. Significance levels are expressed by
y: p<0.006 (q<0.05).
Fig. 3. The ploidy-associated changes in gene expression revealed by variant II analysis (with GO categories as gene sets). Bars represent the mean folds of changes in
the expression of genes mapped to a given GO category. Categories with similar functions are grouped. (A) GO Biological Processes; (B) GOMolecular Function; (C)
GO Cellular Components. Y axis, GO categories; X axis, mean (log-transformed) fold changes. Significance levels are expressed by gray-scale: white: p<0.0001
(q<0.001); light gray: p<0.0008 (q<0.02); dark gray: p<0.005 (q<0.04).
73O.V. Anatskaya, A.E. Vinogradov / Genomics 89 (2007) 70–80
Fig. 3 (continued).
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Genes involved in DNA repair attract particular attention. From
12 DNA repair-related genes, 11 genes increased their ex-Table 2
The overrepresented GO categories (subvariant Ia of analysis)
GO category and direction of changes (↑ or ↓) p value q value a
Biological processes
↑Base-excision repair, DNA ligation 0.001 0.04
↑DNA ligation during DNA repair 0.001 0.04
↑DNA unwinding during replication 0.0002 0.04
↑G2 phase 0.001 0.04
↑G2 phase of mitotic cell cycle 0.001 0.04
↑Aspartyl-tRNA aminoacylation 0.001 0.04
↑Fatty acid desaturation 0.001 0.04
↑Sterol biosynthesis 0.0004 0.04
↑Sterol metabolism 0.001 0.04
↑Biosynthesis 0.0004 0.04
↓Muscle contraction 0.0001 0.04
↓Aerobic respiration 0.0001 0.04
Cell components
↑Endoplasmic reticulum 6.2×105 0.004
↓Mitochondrion 1.2×108 7.8×107
↓Contractile fiber 0.0002 0.008
↓Cytoplasm 0.0005 0.01
↓Myosin 0.0007 0.01
↓Muscle myosin 0.005 0.04
↓Mitochondrial electron transport chain 0.004 0.04
↓Actin cytoskeleton 0.004 0.04
↓Myosin II 0.004 0.04
Molecular functions
↓Structural constituent of muscle 3.8×107 4.6×105
a q value is the false discovery rate.pression and only 1 decreased it. Six of these 11 activated genes
(HMG1, HMG2, RAD50, DNA polymerase sigma, DNA
topoisomerase 1, and retinoblastoma-binding protein 4) are
known to play a key role in the recognition and repair of DNA
double-strand breaks. The increased ability of polyploid cells to
repair DNA double-strand breaks was reported previously for
lymphoma cells [16]. In congruence with activation of cell
defense mechanisms, expression of tumorigenesis-related genes
is changed in direction, suggesting prevention of tumor growth.
The tumor suppressors are activated, whereas the oncogenes are
depressed (Supplementary Table 1). The activation of cell
protection machinery is accompanied by an impairment of
inflammatory response (Table 1, Supplementary Table 1).
Notably, we found an induction of hypoxia-inducible factor-1
(HIF-1) (3.9- and 3.5-fold in heart and liver, respectively) and
the alteration of expression of 37 genes that are regulated directly
via this factor (Supplementary Table 1). These genes participate
in a wide spectrum of processes, including stress response,
immunity, metabolism, transcription, protein turnover, and
proliferation. The expression of the majority of these genes
was changed in an HIF-dependent manner (Table 1, Fig. 2).
Among genes with direct regulation via HIF-1, there were
epidermal growth factor receptor, platelet-derived growth factor
α polypeptide, transferrin receptor, ILGFBP2, inhibin β,
hepatocyte nuclear factor 4, HSP90, enzymes of the tricarbox-
ylic acid cycle, and 5 genes participating in glucose metabolism.
Because thus far only approximately 40 genes are known to be
directly regulated by HIF-1 [18], the HIF-1-controlled genes
seem to be enriched very strongly in the polyploid tissues. Thus,
our data suggest that polyploid cells function under hypoxic
conditions.
Table 3
The detailed results of the fold-direction test (subvariant Ib of analysis)
separately for heart and liver: Mean (log-transformed) folds for functional gene
groups and significance levels of the Mann-Whitney test
Functional groups with subgroups and
direction of changes (↑ or ↓)
Heart Liver
↑DNA repair 0.36±0.07; 0.46±0.08;
p<0.02 p<0.003
↑Response to hypoxia 0.46±0.07; 0.43±0.08;
p<0.00002 p<0.0002
↓Immunity −0.34±0.12; −0.37±0.14;
p<0.05 p<0.02
↓Apoptosis 0.33±0.10; 0.37±0.05;
p<0.01 p<0.01
↑Abiotic stress response 0.30±0.04; 0.33±0.09;
p<0.007 p<0.01
↓Tumorigenesis 0.39±0.09; 0.47±0.01;
p<0.02 p<0.007
↓Respiration −0.56±0.09; −0.45±0.06;
p<0.00004 p<0.0001
↑Glycolytic pathways 0.55±0.06; 0.65±0.10;
p<0.009 p<0.009
↑Fatty acid metabolism 0.30±0.09; 0.33±0.12;
p<0.01 p<0.03
↑Protein turnover 0.43±0.07; 0.47±0.08;
p<0.0001 p<0.00008
↑Proliferation 0.33±0.11; 0.28±0.017;
p<0.02 p<0.001
↑Transport 0.32±0.08; 0.27±0.09;
p<0.0006 p<0.001
↓Cytoskeletal and contractile proteins −0.35±0.13; −0.23±0.09;
p<0.01 p<0.001
↑Transcription 0.25±0.06; 0.30±0.06;
p<0.0001 p<0.0006
↑Signal transduction 0.22±0.08; 0.26±0.09;
p<0.01 p<0.003
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expression of its target genes, we revealed the down-regulation
of genes involved in the production of reactive oxygen species
(Fig. 2) and the activation of the glutathione biosynthesis
pathway (Fig. 2) that participates in oxidative stress protection
[19]. Collectively, these findings suggest that polyploidy
triggers a complex of cell protective changes and that hypoxic
conditions are accompanied by polyploidization.
In general, the revealed activation of stress-related genes is in
good agreement with the indications that polyploidization takes
place under stressful conditions and high physiological tension
[3,7,20,21].
Metabolism
Our data indicate the shift from aerobic to anaerobic energy
production in polyploid tissues (Supplementary Table 2). The
major effect is a dramatic reduction in the expression of genes
encoding enzymes of aerobic respiration. All the applied tests
demonstrate high significance levels, including the evidence for
alteration in 10 biological pathways engaged in oxidative
metabolism (Tables 1–3, Figs. 2 and 3). The average decrease
in expression of these genes is 3.5- and 3-fold in heart andliver, respectively. The shift from aerobic to anaerobic
pathways is also evident from the switch from oxidation of
fatty acids to the oxidation of glucose [18,22]. It is established
that fatty acid oxidation is correlated directly with oxygen
consumption [23]. The rearrangements in metabolic regulators
are accompanied by the stimulation of glucose and cholesterol
metabolism (Tables 1 and 3, Fig. 2).
Importantly, the majority of metabolic rearrangements
found here appeared to be generally accepted features of
hypoxia and oxidative stress. These features are the stimulation
of glycolysis seen in HIF-activated markers (hexose-6-
phosphate dehydrogenase, phosphofructokinase, phosphory-
lase, and adenylate cyclase 7), the impairment of glycogen
biosynthesis, and the hyperexpression of HIF (included also in
the category of stress-related genes) [18,22]. These results are
consistent with the picture observed at the cellular and organ
levels [1,3,4].
Protein turnover
Surprisingly, the switch from aerobic to anaerobic energy
production is accompanied by the activation of protein turnover
(Supplementary Table 3). We found an up-regulation of genes
involved in both protein biosynthesis (ribosome biogenesis,
translation, and tRNA and amino acid biosynthesis) and protein
catabolism (proteasome protein degradation and amino acid
decomposition). All tests confirm this activation, including
significant changes in 12 biological pathways related to protein
turnover (Tables 1 and 3, Figs. 2 and 3). The most prominent
activation was found in genes engaged in ribosome biogenesis
(Tables 1–3, Figs. 2 and 3). This finding is consistent with the
morphological data indicating the increase in nucleolar area
with polyploidization in cardiomyocytes and meristematic cells
of wheat [10,24].
Transcription
Genes implicated in transcription were predominantly
activated (Tables 1 and 2, Fig. 2, Supplementary Table 4).
(This is in general agreement with the above-mentioned
prevalence of activated genes over suppressed genes). We
found the induction of basic and specific transcription factors
and the activation of mRNA metabolism, processing, and
splicing. Notably, the pattern of alteration of specific
transcription factors matched well with alteration in the
corresponding functional groups. As stated above, the up-
regulation of HIF is in good agreement with the elevated
mRNA levels of numerous HIF-induced genes (Supplemen-
tary Tables 1-8). The switch from aerobic to anaerobic
metabolism can be partly explained by the induction of
hepatocyte nuclear factor 4, which is known to be a stimulator
of glucose and lipid exchange [57]. Modifications in
transcription revealed here are possibly related to the reaction
of polyploid organs to unfavorable physiological conditions.
Thus, the activation of general transcription factors (TFIIB and
TFIIA) and transcription factors coordinating stress response,
immunity, proliferation, and metabolism was generally
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thermia, hypoxia, and toxicants [25].
Cellular transport and signal transduction
In concert with the activation of protein synthesis and
transcription, genes involved in signal transduction and
transport are predominantly activated (Supplementary Tables
5 and 6). We found an increased activity of nucleo-cytoplasmic
and protein transport (Table 1, Fig. 3). Ionic transport
demonstrates substantial modification: iron, magnesium, and
phosphate ion transporters are induced, whereas copper and
potassium transporters are repressed (Supplementary Table 5).
Among genes related to cell signaling, the most prominent
changes were shown by transcripts involved in cell survival. We
found an induction of PI3 kinase, KRAS, and epidermal growth
factor signal cascades (Fig. 2).
Cytoskeleton
Genes engaged in cytoskeleton maintenance and muscle
contraction are highly depressed (Tables 1 and 2, Figs. 2 and
3, Supplementary Table 7). The major change is found for
myosin light polypeptides 1, 2, and 3, and myomesin 1. In
heart, the reduction of mRNA levels of these genes reaches
204-, 168-, 6-, and 60-fold, respectively. We revealed an
overrepresentation of genes related to cytoskeleton mainte-
nance among the down-regulated transcripts (Tables 1 and 2,
Fig. 2). These findings help explain the link between the
decrease in cardiac contraction ability and cardiomyocyte
polyploidization [4,7,10]. Cytoskeletal modification is also
evident from the differing expression of several actin activity
adaptors.
Proliferation and differentiation
Genes involved in cell proliferation were predominantly
activated. The up-regulated genes were enriched with positive
regulators of the cell cycle and genes involved in G2, M
phase, and cytokinesis (contractile ring) (Tables 1 and 2, Figs.
2 and 3, Supplementary Table 8). These changes were
accompanied by an activation of two biological pathways
related to the cell cycle (Supplementary Table 8). Consistent
with an increased proliferative potential, polyploid organs
demonstrate a number of features that are known to be typical
for organ survival under hypoxia. These features are the
depression of aerobic respiration, cytoskeleton maintenance,
and immune response, the induction of glycolytic and
hypoxia-inducible pathways, transcription, cell motility, ribo-
some biogenesis, and protein turnover, and enhanced protec-
tion from apoptosis [18].
Discussion
Our data indicate that genome multiplication in mammalian
tissues is associated with alteration in a wide range of cellular
processes. We do not state that all these changes in geneexpression are directly caused by polyploidy. In addition to
ploidy-dependent genes, there may be genes whose expression
was changed as a consequence of conditions in which polyploid
cells find themselves. (Therefore, we used the term ploidy-
associated throughout.) We suggest that these conditions can be
the cause of genome multiplication.
It is interesting that many Gene Ontology (GO) categories
with up-regulated genes (ribosome biogenesis, protein turnover,
transcription, proliferation, transport, signal transduction, and
glycolysis) and down-regulated genes (aerobic respiration,
defense response, and apoptosis), which we found in polyploid
heart and liver, are similar to those GO categories in which there
are duplicated genes (ancient polyploid) Arabidopsis were
preferentially kept as duplicates (similarly to up-regulated genes
in our study) or lost (similarly to down-regulated genes) [26].
This fact suggests a certain relationship between organismal and
somatic polyploidization. (For instance, adaptation to stress,
which seems to be involved in the appearance of somatic
polyploidy, may play a role in the evolutionary fixation of
organismal polyploidy.)
It is well established that polyploid tissues possess a unique
ability to simultaneously conduct proliferation and differenti-
ation [1,2,20]. For the vast majority of diploid tissues, these
functions are incompatible and separated in time (and/or space)
and energy sources. Proliferation takes energy from anaerobic
metabolism, whereas protein synthesis uses energy produced by
aerobic respiration [5,6]. This separation seems to be a defense
against DNA damage by reactive oxygen species during
replication and has been suggested to be a very ancient and
fundamental compartmentalization of metabolic functions [5,6].
The ploidy-associated changes in gene expression revealed here
probably reflect features enabling the cells to combine
proliferative and tissue-specific functions. The greatest changes
are the depression of aerobic respiration and the induction of
glycolysis (Tables 1–3, Figs. 2 and 3). Glycolysis is known to
participate in energy production and the synthesis of nucleo-
tides, amino acids, phospholipids, and sialic acids [27] (see also
http://www.metabolic-database.com).
These rearrangements seem to create a special type of
metabolism that can be considered intermediate between aerobic
and anaerobic. The link between polyploidization and oxygen
deficiency is also evident from the up-regulation of HIF-1 and
the corresponding alteration in expression of 33 (of 40 known)
HIF-1-regulated genes (Supplementary Table 1). In addition,
hypoxia-associated changes are manifested in basic physiolog-
ical processes, including the metabolic switch, activated
proliferation, transcription, protein turnover, and cell signaling
corresponding to these processes [18,22]. Data from the
literature confirm the association between genome multiplica-
tion and impairment of aerobic energy production. Thus, the
results of electronmicroscopy showed a lower volume density of
mitochondria in polyploid cardiomyocytes and hepatocytes than
in diploid ones [3,10]. The wide-scale analysis of mammalian
mitochondrial gene expression revealed lower mitochondrial
activity in human heart than in mouse heart [28]. Also, the
increase in cell ploidy under hypoxia was registered in
various tumor cells, cells of the granular layer of the
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cytes [29–31]. Another important hallmark of polyploid
organs seems to be the orchestration of gene activity to
prolong cell survival and protect cells from hypoxia, DNA
lesions, apoptosis, tumorigenesis, toxicants, and oxidative
stress (due to an increased glutathione biosynthesis). These
results are in good agreement with the literature. Thus, the
increased capacity of polyploid cells to repair DNA double-
strand breaks and to stand against apoptosis was shown in
lymphoma cells, fibroblasts, and filamentous cells of Ustilago
maydis [16,17,32]. The triggering of antioxidant and drug
detoxifying systems with polyploidization was found in rat
hepatocytes [33]. We suggest that the recruitment of cell
protective mechanisms in polyploid organs may be caused by
permanent mild hypoxia presumably arising from decreased
blood supply. The link between polyploidy and impaired
blood flow was registered in human heart with narrowed and
genetically disturbed coronary vessels and after infarct and
ischemia [34,35]. The same trend was observed in rat liver. In
the hepatic lobule, the decrease in blood supply decreases
from the portal to the central zone of the lobule [36].
Consistently, periportal hepatocytes contain more LDH
activity (final electron acceptor under anaerobic conditions)
than pericentral hepatocytes [37]. The gradient of hepatocyte
ploidy level within a hepatic lobule coincides with the
decrease in oxygen supply, demonstrating the increase from
the portal to the central zone of the lobule [36]. Similarly, in
aging rat liver (which accumulates an enormous amount of
polyploid hepatocytes [1]), sinusoids show changes in the
endothelium that cause a decrease in hepatocyte oxygenation
[38].
It is known that polyploid cells have a lower surface to
volume ratio both in the nucleus and in the whole cell [1]. In
accordance with this fact, our data demonstrate alterations in
gene expression, which suggest activation of transcription,
protein transport, and nucleo-cytoplasmic transport, rearrange-
ment of the cytoskeleton, and the enhancement of signal
transduction pathways. The data on yeast and filamentous cells
of U. maydis also indicate that polyploidy is associated with
alterations of the cytoskeleton, transport, and the signal
transduction system [32].
The shift from oxidative to glycolytic pathways is known to
be associated with the impairment of tissue-specific functions
that take energy predominantly from aerobic respiration [5,6].
This metabolic shift in polyploid organs is strongly supported
by the present data. Furthermore, we found clear indications of
the impairment of contractile and cytoskeletal proteins
(including myosin light polypeptides 1, 2, and 3, and myomesin
1). It is noteworthy that some features of polyploid tissues
(impaired immunity, triggering of HIF-1, activation of tran-
scription, protein turnover, ribosome biogenesis, and switching
from aerobic to anaerobic metabolism) resemble changes found
in tissues containing transformed cells [27,37,39] (see also
http://www.metabolic-database.com).
Collectively, our data suggest that genome multiplication is
associated with negative consequences for organ function.
Therefore, they help explain why the polyploidization of car-diomyocytes and hepatocytes is accompanied by a decrease in
organ functional capacity and protein content per genome
[9,10].
Genome multiplication in somatic tissues, however, is
widespread in nature and therefore should have a certain
adaptive significance. We found that changes in gene expression
associated with polyploidy are essentially similar to those
described in long-living mutants. Recent studies on Caenor-
habditis elegans and Drosophila melanogaster showed that a
longer lifespan is associated with the up-regulation of genes
involved in DNA repair, general stress responses, and depression
of aerobic metabolism [40]. Our data indicate a clear link
between polyploidy and orchestration of gene expression to
prolong cell survival (including protection from apoptosis, DNA
damage, hypoxia, and oxidative stress) and to increase
proliferative ability. Experiments with recently discovered
ploidy-associated protein kinase (PAPK) also suggested pro-
longed cell survival in polyploid cells [17]. It was shown that
PAPK suppresses caspase-mediated apoptosis and stimulates
JNK and ERK6/p38γ cell growth and survival pathways [17].
The increased protection of polyploid cells from DNA lesions
and apoptosis was demonstrated in experiments on cells with
severe genotoxic lesions after gamma irradiation [16].
The involvement of genome multiplication in cell pro-
tection is in good agreement with the comparative,
ontogenetic, and biomedical data, which indicate that all
tissues containing polyploid cells are subjected to stress
[2,20]. This stress can be caused by a variety of factors, such
as inflammation, elevated metabolism, aging, repair process-
es, and physiological and pathological overload [1,2,7,20,29–
36]. The highest average cardiomyocyte ploidy (∼10n) was
found in swans and ducks [41], which perform persistent 10-
h flight in a hypoxic atmosphere at approximately 10,000 m
above sea level (at temperatures below −40 °C and oxygen
concentrations below 30% of that at sea level) [42]. A tight
link of cardiomyocyte ploidy with hypertension and ischemic
heart disease is well recognized [34,35]. In the liver, the
elevated ploidy level was registered after partial hepatectomy,
during infectious disease, and in dysplastic liver nodules
(which are premalignant events) [1,20,43–45]. In the normal
mammalian heart and liver, the peak of polyploidization
takes place in the period of maximal workload of the
growing organ [1]. Therefore, the time of genome multipli-
cation is considered to be a critical period in organ formation
[7,10,41,46].
The measurement of ploidy level could be a sensitive and
simple assay of organ tensions. The elevated ploidy level in
biopsies may serve as an indicator of early alteration of tissue.
The array-based assay of changes in gene expression (similar to
those found in the present work) can probably reveal these
alterations at even earlier stages.Materials and methods
The data on expression levels of human and mouse genes were taken from
the Gene Expression Atlas [47] (http://symatlas.gnf.org/SymAtlas). They
present the results of oligonucleotide microarray experiments. The uniform
78 O.V. Anatskaya, A.E. Vinogradov / Genomics 89 (2007) 70–80platforms were used for all human (U133A+GNF1B) and mouse (GNF1M)
tissues. The signals from probes on the chip corresponding to the same gene
were averaged; the samples representing the same tissue were also averaged.
Only probes that presented the characterized genes (i.e., those with links to the
LocusLink/Entrez Gene database [48]) and that were homologous between
human and mouse, were used. The homology was established using the
HomoloGene database [48] (10,943 homologous genes were found).
To remove the effect of species specificity on gene expression, we
normalized the expression level of a given gene in a studied tissue (heart or liver)
of a given species (human or mouse) to the average (log-transformed)
expression level of this gene in other tissues of this species. Only normal
tissues that were homologous for human and mouse were used (32 tissues). (In
addition to removing the effect of species specificity, comparison of the relative
expression levels was found to be more reliable in the recent survey of data
portability across microarray platforms [49,50]). Human and mouse have
inverse patterns of polyploidization in cardiomyocytes vs. hepatocytes.
(Notably, heart and liver are the only definitive mammalian organs where
somatic polyploidy demonstrates substantial development [1]). Humans have
polyploid heart and almost completely diploid liver, whereas mice have weakly
polyploid heart and highly polyploid liver [1,7,10,11].
We confirmed and refined the literature data, using cytophotometry and
image analysis. For this purpose, we measured ploidy levels in isolated
cardiomyocytes and hepatocytes from human and mouse as described in [10].
The specimens of human autopsy tissues (from 12 subjects) were obtained from
First Medicine University Hospital (St. Petersburg). The mouse tissues (from 11
animals) were obtained from the vivarium of our institute. At least 500 cells
were photometried from each sample. The mean level of cell ploidy was
calculated using the formula: PLD=Σi*ni, where PLD is the mean number of
genomes per cell and ni is the relative number of cardiomyocytes of the i-class
of ploidy. The mean level of nuclear ploidy was calculated similarly as
NPLD=Σj*nj, where NPLD is the mean number of genomes per nucleus and nj
is the relative number of nuclei of j-ploidy class. The human cardiomyocytes
and hepatocytes were found to contain (7.08±0.2)n and (2.12±0.03)n per cell,
respectively. The mouse cardiomyocytes and hepatocytes showed (3.54±0.07)n
and (5.03±0.11)n per cell, respectively. It should be noted that in the (weakly
polyploid) human liver and mouse heart, polyploidy is presented mostly by cells
with two diploid nuclei; i.e., these organs contain a negligible amount of cells
with really polyploid nuclei. Thus, average nuclear ploidy in human liver is
(2.05±0.008)n, whereas in mouse liver it is (5.47±0.1)n. Similarly, average
nuclear ploidy in mouse heart is (2.05±0.007)n, whereas in human heart it is
(4.04±0.05)n. In other words, human hepatocytes and mouse cardiomyocytes
have practically diploid nuclei, whereas human cardiomyocytes and mouse
hepatocytes have predominantly polyploid nuclei. Therefore, to reveal ploidy-
associated genes, we compared the species-normalized (log-transformed)
expression levels in homologous polyploid vs. diploid tissues in a crisscross
manner (i.e., in human heart vs. mouse heart and in mouse liver vs. human liver).
(For human, there are data in the Gene Expression Atlas not only on the total
heart but also on cardiomyocytes separately; therefore, we used the
cardiomyocyte data as they were presumably more pure).
To find ploidy-associated genes that are independent of a tissue, we chose
genes whose expression was changed in the same direction in both crisscross
comparisons (human heart vs. mouse heart and mouse liver vs. human liver). At
least one gene in the compared pair of homologous genes should be expressed in
each pair of compared tissues. As was recommended based on extensive PCR
validation [47,51], a gene was regarded as being expressed if its (non-species-
normalized) signal level exceeded a conservative threshold of the data-set
median. Also, we excluded tissue-specific genes. It is known that on the
histogram of genes expressed in a particular tissue (where the X axis of the
histogram represents the number of tissues where a given gene is also expressed),
the tissue-specific genes do not form a clear-cut peak, but show a plateau of genes
with gradually increasing tissue specificity, i.e., with a gradual decrease in the
number of tissues where these genes are also expressed (Fig. 2B in [52]). The
picture was similar with the present data set (not shown). Therefore, to exclude
tissue-specific genes, we took an arbitrary threshold used previously [52,53] and
excluded genes expressed in less than a quarter of tissues studied (i.e., in less than
eight tissues), which gives 6585 genes.
Genes that satisfied the above criteria were subjected to two main variants of
analysis. In the first variant (with two subvariants, Ia and Ib), we preliminarilyselected genes that showed a greater than twofold difference in expression level
in the same direction in both crisscross comparisons (i.e., in human heart vs.
mouse heart and in mouse liver vs. human liver). The twofold threshold was used
previously in many works on gene expression e.g., [53–55]. Within the extracted
sample, we classified genes into functional groups (modules) using Gene
Ontology categories and the literature (as shown in Supplementary Tables 1-10).
To confirm these groups, we checked them for gene frequency overrepresentation
(in relation to the total data set, i.e., 6585 genes) using hypergeometric
probability distribution (with correction for multiple comparisons based on
calculation of false discovery rate). Thus, this subvariant of analysis (Ia) was
performed similarly to that used by Segal et al. [13], where genes with twofold
(and greater) changes were further checked for overrepresentation with regard to
the total data set, using GO categories and other predefined gene sets. The test on
gene frequency overrepresentation is often used now. However, it is too
conservative because it does not take into account the direction and the extent of
changes in expression. In a more elaborate variant of overrepresentation analysis,
it was used separately for up- and down-regulated genes [13]. (We performed it in
a similar way.) However, it still does not take into account the extent of changes
and the difference between inducers and inhibitors of a process. Therefore, in the
second subvariant of analysis (Ib), which we called a fold-direction test, we used
the average of (log-transformed) fold changes for a given gene group, where the
folds of up-regulated genes were taken with a plus sign, whereas the folds of
down-regulated genes were taken with a minus sign. Similarly, the folds of
inducers of a process were taken with a plus sign and the folds of inhibitors were
taken with a minus sign. The signs were combined in the usual way; i.e., if a gene
was both an inhibitor and down-regulated, its fold was taken with a plus sign.
[The information on inducers and inhibitors was taken from Gene Ontology
(http://www.geneontology.org), the Metabolic Database (http://www.metabolic-
database.com), and the literature.] We checked then whether the average fold of a
given gene group was significantly above or below zero in both crisscross
comparisons (i.e., in human heart vs. mouse heart and in mouse liver vs. human
liver), using the Mann-Whitney test.
In the second main variant of analysis, we followed the logic of
simultaneous discovery of functional gene groups with altered expression,
which did not consider individual genes at all, as it was performed recently
[14,15], with modification. In this variant, the average (log-transformed) fold
changes corresponding to the predefined gene sets were checked against the
average fold of the total data set (6585 genes). We used the mean pairwise fold
change of both crisscross comparisons (i.e., human heart vs. mouse heart and
mouse liver vs. human liver) in this test. The predefined gene sets were
prepared using Gene Ontology categories (separately for Biological Processes,
Molecular Functions, and Cellular Components sections of Gene Ontology)
[57] and pathways compilations from the Molecular Signature Database
(MsigDb) [14], KEGG [56] and Reactome [58] (using Entrez Gene mapping),
and HumanCyc [59]. In the case of Gene Ontology categories, we collected for
each category all its subcategories (using GO graphs), and a gene was regarded
as belonging to a given category if it was mapped to any of its subcategories
(in Entrez Gene). For estimation of significance level, we performed 10,000
random samplings from the total data set (of a size equal to that of a tested
gene group). After obtaining two-tailed significance levels (p values), we
estimated false discovery rates for correction for multiple comparisons using
the q-value program [60].Acknowledgments
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